AF
DNLI icon

Advisornet Financial’s Denali Therapeutics DNLI Stock Holding History

Advisornet Financial’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40
Closed -$1.17K – 2036
2024
Q3 		$1.17K Buy
+40
New +$991 ﹤0.01% 1901
2021
Q3 		– Sell
-50
Closed -$4K – 1908
2021
Q2 		$4K Hold
50
– – ﹤0.01% 1597
2021
Q1 		$3K Hold
50
– – ﹤0.01% 1582
2020
Q4 		$4K Hold
50
– – ﹤0.01% 1464
2020
Q3 		$2K Hold
50
– – ﹤0.01% 1552
2020
Q2 		$1K Buy
+50
New +$1.18K ﹤0.01% 1666

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Advisornet Financial's DNLI Position: Q4 2024 in Review

Advisornet Financial sold out of Denali Therapeutics (DNLI) in Q4 2024, closing a stake of 40 shares — an estimated $1.17K sold.

Advisornet Financial first reported a position in DNLI in Q2 2020 and held it in 6 quarters. The position peaked at $4K in Q2 2021. 223 funds tracked by Wall St. Rank hold DNLI as of Q4 2024.

  • Advisornet Financial reported no remaining Denali Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Advisornet Financial sold 40 Denali Therapeutics shares in Q4 2024, an estimated $1.17K.
  • Advisornet Financial first reported a position in Denali Therapeutics in Q2 2020 and held it in 6 quarters.
  • Advisornet Financial's Denali Therapeutics position peaked at $4K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Denali Therapeutics as of Q4 2024.

Based on Advisornet Financial's 13F filing for Q4 2024, filed 13 Jan 2025.